Clinical Trials in São Paulo, São Paulo

3 recruiting

Showing 120 of 20 trials

Recruiting
Phase 3

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

AbbVie698 enrolled316 locationsNCT04928846
Recruiting
Phase 3

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Mirati Therapeutics Inc.630 enrolled337 locationsNCT06875310
Recruiting
Phase 2

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

Breast Cancer
Hoffmann-La Roche80 enrolled7 locationsNCT07405801
Recruiting
Phase 3

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Hoffmann-La Roche1,050 enrolled351 locationsNCT06065748
Recruiting
Phase 3

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer
Hoffmann-La Roche450 enrolled210 locationsNCT06790693
Recruiting
Phase 3

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled524 locationsNCT06492616
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer
Hoffmann-La Roche230 enrolled187 locationsNCT05894239
Recruiting
Phase 3

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Phase 2

A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

Breast Cancer
Hoffmann-La Roche60 enrolled25 locationsNCT07054190
Recruiting
Phase 1Phase 2

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

IDEAYA Biosciences208 enrolled39 locationsNCT07174583
Recruiting
Phase 4

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Cognitive FunctionMotor FunctionContrast Media
Guerbet2,076 enrolled51 locationsNCT04373564
Recruiting
Not Applicable

Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery

Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)
AC Camargo Cancer Center164 enrolled1 locationNCT07268846
Recruiting

Prevalence of Emerging Treatment-induced Mutations in Metastatic ER-positive Breast Cancer.

Metastatic Breast Cancer
AstraZeneca70 enrolled1 locationNCT06417801
Recruiting
Not Applicable

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Breast CancerBreast Cancer Recurrent
University Health Network, Toronto171 enrolled15 locationsNCT05592938
Recruiting
Phase 3

CRYoablation for Small Tumors As Local Treatment - SIX Trial

Breast CancerBreast Neoplasm
Hospital do Coracao750 enrolled2 locationsNCT06839001
Recruiting
Phase 2

Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction

Breast CancerHeart Failure
Population Health Research Institute130 enrolled8 locationsNCT04680442
Recruiting
Not Applicable

Sentinel Lymph Node Biopsy Versus No Axillary Surgery in Early Breast Cancer

Breast Cancer
University of Campinas, Brazil800 enrolled18 locationsNCT05315154
Recruiting
Not Applicable

Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy

Malignant Breast Neoplasm
Instituto Brasileiro de Controle do Cancer36 enrolled1 locationNCT05665920
Recruiting
Phase 2

Local Therapy for ER/PR-positive Oligometastatic Breast Cancer

Breast Cancer
Instituto do Cancer do Estado de São Paulo74 enrolled1 locationNCT04698252
Recruiting
Not Applicable

Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving Surgery

Malignant Neoplasm of Breast
Instituto Brasileiro de Controle do Cancer36 enrolled1 locationNCT04669873